Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling

Published:2011-08-08 Issue:2 Volume:25 Page:369-378
ISSN:0952-3480
Container-title:NMR in Biomedicine
language:en
Short-container-title:NMR Biomed.

Author:

Cao Maria D.¹,Sitter Beathe¹,Bathen Tone F.¹,Bofin Anna²,Lønning Per E.³⁴,Lundgren Steinar¹⁵⁶,Gribbestad Ingrid S.¹

Affiliation:

1. Department of Circulation and Medical Imaging; Norwegian University of Science and Technology (NTNU); 7489 Trondheim Norway

2. Department of Laboratory Medicine, Children's and Women's Health; Norwegian University of Science and Technology (NTNU); 7489 Trondheim Norway

3. Department of Oncology; Haukeland University Hospital; 5021 Bergen Norway

4. University of Bergen; 5020 Bergen Norway

5. Department of Oncology; St Olav University Hospital; 7006 Trondheim Norway

6. Department of Cancer Research and Molecular Medicine; NTNU

Funder

Clinical medicine and public health

Publisher

Wiley

Subject

Spectroscopy,Radiology Nuclear Medicine and imaging,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/nbm.1762/fullpdf

Reference47 articles.

1. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J. Natl. Cancer Inst. Monogr.,2001

2. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis;Mauri;J. Natl. Cancer Inst.,2005

3. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer;Makris;Ann. Oncol.,1998

4. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions;Mathew;Eur. J. Surg. Oncol.,2009

5. Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma;Jones;Br. J. Cancer,2006

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A critical appraisal of the role of metabolomics in breast cancer research and diagnostics;Clinica Chimica Acta;2024-07

2. Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes;Oncogenesis;2024-06-13

3. EDI3 knockdown in ER-HER2+ breast cancer cells reduces tumor burden and improves survival in two mouse models of experimental metastasis;Breast Cancer Research;2024-05-30

4. Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes;Journal of Translational Medicine;2023-11-27

5. The Relationship between Histological Composition and Metabolic Profile in Breast Tumors and Peritumoral Tissue Determined with 1H HR-MAS NMR Spectroscopy;Cancers;2023-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3